LexDanaLexDanabeta
Inventor

Nigel C. Phillips

Inventor
Pointe-Claire, CA

Overview

24→
Patents
1987–2015
Patent span
Human necessities
Primary field (CPC A)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C12NMicroorganisms or enzymes16%
C07HSugars6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology5%
B82YSpecific uses or applications of nanostructures2%
C07KPeptides2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
9,220,765'Bacterial ribonucleic acid cell wall compositions and methods of making and using them'20159,180,176'Bacterial ribonucleic acid cell wall compositions and methods of making and using them'20159,180,177'Bacterial ribonucleic acid cell wall compositions and methods of making and using them'20159,138,469'Bacterial ribonucleic acid cell wall compositions and methods of making and using them'20159,044,422'Bacterial ribonucleic acid cell wall compositions and methods of making and using them'20158,350,016'Oligonucleotide compositions and their use to induce apoptosis'20137,893,242'Oligonucleotide compositions and their use to induce apoptosis'20117,662,792'Modulation of Fas and FasL expression'20107,635,686'Therapeutically useful triethyleneglycol cholesteryl oligonucleotides'20097,371,734'Oligonucleotide compositions and their use for the modulation of immune responses'20087,200,531'Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides'20077,199,228'Oligonucleotide compositions and their use to induce apoptosis'20077,157,436'Therapeutically useful synthetic oligonucleotides'20077,125,858'Hyaluronic acid in the treatment of cancer'20067,087,586'Oligonucleotide compositions and their use to induce differentiation of cells'20066,890,911'Method for the treatment of inflammation'20056,809,081'Chemotherapeutic composition and method'20046,794,368'Composition and method for inducing apoptosis in prostate cancer cells'20046,329,347'Composition and method for the treatment of bladder cancer'20016,326,357'Bacterial cell complex composition and method of use'20016,139,844'Method for treating or eliminating a parasitic disease'2000RE035706'Lipophila derivatives of muramylpeptides having properties of activating macrophages and compositions containing them'19974,939,122'Lipophile derivatives of muramylpeptides having properties of activating macrophages and compositions containing them'19904,663,311'Derivatives of muramyl-peptides and of steroids having macrophage-activating properties'1987

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1987–2015Patents assigned to PHILLIPS NIGEL C (3)· patent assignee history
1987Based in Bailly, FR· patent location history
1990–2015Based in Pointe-Claire, CA· patent location history
2001–2013Patents assigned to BIONICHE LIFE SCIENCES INC (14)· patent assignee history
2007–2008Based in Point Claire, CA· patent location history
2013–2015Patents assigned to FILION MARIO C (2)· patent assignee history
2013–2015Patents assigned to HOLAN ZDENEK RICHARD (2)· patent assignee history
2015Patents assigned to BIONICHE UROLOGY IP INC (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BIONICHE LIFE SCIENCES INC142001–2013
BIONICHE UROLOGY IP INC42015
PHILLIPS NIGEL Cself31987–2015
FILION MARIO C22013–2015
HOLAN ZDENEK RICHARD22013–2015
Locations
LocationPatentsSpan
Pointe-Claire, CA211990–2015
Point Claire, CA22007–2008
Bailly, FR11987